— Know what they know.
Not Investment Advice
Also trades as: THYROCARE.NS (NSE) · $vol 4M

THYROCARE.BO BSE

Thyrocare Technologies Limited
1W: -5.7% 1M: -9.3% 3M: -3.4% YTD: +31.5% 1Y: -61.0% 3Y: -2.9% 5Y: -56.0%
₹536.00 ($5.57)
+1.65 (+0.31%)
 
BSE · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 35 · ₹85.3B mcap · 46M float · 0.182% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹85.3B ($885.7M)
52W Range342.55-662
Volume7,857
Avg Volume84,116
Beta0.47
Dividend₹9.33
Analyst Ratings
No analyst coverage
Company Info
CEORahul Franklin Guha
Employees2,092
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2016-05-10
D/37-3, TTC Industrial Area
Navi Mumbai, MA 400703
IN
91 22 4125 2525
About Thyrocare Technologies Limited

Thyrocare Technologies Limited, an Indian enterprise founded in 1996 and based in Navi Mumbai, operates as a subsidiary of Docon Technologies Private Limited. The company provides a comprehensive suite of diagnostic testing services to individuals, clinics, and medical facilities throughout India. Its operations are structured into three distinct divisions: Diagnostic Testing Services, Imaging Services, and Other Services. Thyrocare focuses on conducting a broad spectrum of medical diagnostic analyses and test bundles aimed at the timely detection and effective management of various health conditions and diseases. These encompass thyroid dysfunctions, growth disorders, metabolic imbalances, autoimmune conditions, diabetes, anaemia, cardiovascular issues, infertility, COVID-19, and a range of infectious diseases. A prominent offering is the Aarogyam brand, which delivers extensive wellness and proactive health screening packages. In addition to its testing services, the company supplies medical devices like glucometers and glucostrips under the Sugarscan label, along with other consumables and radiopharmaceuticals.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms